Used as an intermediate in the synthesis of targeted cancer therapies, particularly in tyrosine kinase inhibitors. Its structure supports binding to specific kinase domains involved in tumor growth signaling pathways. Commonly applied in research and development of oncology drugs, especially those targeting epidermal growth factor receptor (EGFR) mutations. Also utilized in preclinical studies to evaluate antitumor activity and pharmacokinetic profiles.